Deferring Autologous Stem Cell Transplantation for Consolidation of Minimal Residual Disease in Multiple Myeloma

• Published in: Seminars in oncology Vol. 43; no. 6; pp. 709 - 711
• Main Authors: Braunstein, Marc, MD, PhD, Niesvizky, Ruben, MD
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.12.2016
• Subjects: Autologous transplantation; Hematology, Oncology and Palliative Medicine; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Minimal residual disease; Multiple Myeloma - therapy; Myeloma; Neoplasm, Residual - therapy; Transplantation, Autologous; Myeloma; minimal residual disease; autologous transplantation; Minimal residual disease; Autologous transplantation

The expanding armamentarium of novel agents used in combination to treat multiple myeloma (MM) can induce clinical responses in most newly diagnosed patients, with encouraging outcomes observed in the relapsed/refractory setting. Highly sensitive techniques to detect minimal residual disease (MRD) a...